Pancreatic Ductal Adenocarcinoma (PDAC) is a ravaging disease with a poor prognosis, requiring a more detailed understanding of its biology to foster the development of effective therapies. The unsatisfactory results of treatments targeting cell proliferation and its related mechanisms suggest a shift in focus towards the inflammatory tumor microenvironment (TME). Here, we discuss the role of cancer-secreted proteins in the complex TME tumor-stroma crosstalk, shedding lights on druggable molecular targets for the development of innovative, safer and more efficient therapeutic strategies.
胰腺导管腺癌(PDAC)是一种预后极差的侵袭性疾病,需要对其生物学机制进行更深入的理解以推动有效疗法的开发。针对细胞增殖及其相关机制的治疗方案效果不佳,提示应将研究重点转向炎症性肿瘤微环境(TME)。本文探讨了肿瘤分泌蛋白在复杂的TME肿瘤-间质相互作用中的功能,为开发创新、安全且高效的治疗策略揭示了可成药的分子靶点。
Pancreatic Cancer-Secreted Proteins: Targeting Their Functions in Tumor Microenvironment